Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025
Elutia (Nasdaq: ELUT), a pioneer in drug-eluting biomatrix technologies, has scheduled the release of its fourth quarter and full year 2024 financial results for Thursday, March 6, 2025, after market close. The company will host a conference call and webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day. Management will be available for discussion during the call, which can be accessed through U.S. (877-407-8029) and International (201-689-8029) dial-in numbers using Conference ID 13751810. A live and archived webcast will be available on the company's investor relations website.
Elutia (Nasdaq: ELUT), pioniere nelle tecnologie biomatrix a rilascio di farmaci, ha programmato la pubblicazione dei suoi risultati finanziari del quarto trimestre e dell'anno intero 2024 per giovedì 6 marzo 2025, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica e un webcast alle 16:30 ora orientale / 13:30 ora del Pacifico nello stesso giorno. La direzione sarà disponibile per discussioni durante la chiamata, che può essere accessibile tramite i numeri di telefono statunitensi (877-407-8029) e internazionali (201-689-8029) utilizzando l'ID conferenza 13751810. Un webcast dal vivo e archiviato sarà disponibile sul sito web delle relazioni con gli investitori dell'azienda.
Elutia (Nasdaq: ELUT), pionera en tecnologías de biomatriz con liberación de fármacos, ha programado la publicación de sus resultados financieros del cuarto trimestre y del año completo 2024 para el jueves 6 de marzo de 2025, después del cierre del mercado. La compañía llevará a cabo una conferencia telefónica y un webcast a las 4:30 p.m. hora del Este / 1:30 p.m. hora del Pacífico el mismo día. La dirección estará disponible para discusión durante la llamada, a la que se puede acceder a través de los números de marcado de EE. UU. (877-407-8029) e Internacional (201-689-8029) utilizando el ID de conferencia 13751810. Un webcast en vivo y archivado estará disponible en el sitio web de relaciones con los inversores de la empresa.
엘루티아 (Nasdaq: ELUT), 약물 방출 바이오매트릭스 기술의 선구자로, 2024년 4분기 및 연간 재무 결과 발표를 2025년 3월 6일 목요일, 시장 마감 후로 예정하고 있습니다. 회사는 같은 날 동부 표준시 기준 오후 4시 30분 / 태평양 표준시 기준 오후 1시 30분에 전화회의 및 웹캐스트를 개최할 것입니다. 경영진이 통화 중 논의를 위해 참석할 예정이며, 미국(877-407-8029) 및 국제(201-689-8029) 전화번호를 통해 회의 ID 13751810을 사용하여 접근할 수 있습니다. 실시간 및 아카이브된 웹캐스트는 회사의 투자자 관계 웹사이트에서 이용 가능합니다.
Elutia (Nasdaq: ELUT), un pionnier dans les technologies de biomatrices à libération de médicaments, a programmé la publication de ses résultats financiers du quatrième trimestre et de l'année complète 2024 pour le jeudi 6 mars 2025, après la clôture du marché. L'entreprise organisera une conférence téléphonique et un webinaire à 16h30 heure de l'Est / 13h30 heure du Pacifique le même jour. La direction sera disponible pour des discussions durant l'appel, accessible par les numéros de téléphone américains (877-407-8029) et internationaux (201-689-8029) en utilisant l'ID de conférence 13751810. Un webinaire en direct et archivé sera disponible sur le site web des relations investisseurs de l'entreprise.
Elutia (Nasdaq: ELUT), ein Pionier in der Technologie von medikamentenfreisetzenden Biomatrixen, hat die Veröffentlichung seiner Finanzergebnisse für das vierte Quartal und das gesamte Jahr 2024 für Donnerstag, den 6. März 2025, nach Börsenschluss angesetzt. Das Unternehmen wird am selben Tag um 16:30 Uhr Eastern Time / 13:30 Uhr Pacific Time eine Telefonkonferenz und einen Webcast veranstalten. Das Management wird während des Anrufs für Diskussionen zur Verfügung stehen, die über die US-Nummer (877-407-8029) und die internationale Nummer (201-689-8029) mit der Konferenz-ID 13751810 zugänglich sind. Ein Live- und Archiv-Webcast wird auf der Investor-Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
SILVER SPRING, Md., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its fourth quarter and full year 2024 financial results after market close on Thursday, March 6, 2025. Members of the Company’s management team will host a conference call and webcast starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day.
The conference call can be accessed using the following information:
Webcast: Click here
U.S. Investors: 877-407-8029
International Investors: 201-689-8029
Conference ID: 13751810
Please log in approximately 10 minutes prior to the scheduled start time. A live and archived webcast of the event will be available on the “Investors” section of the Elutia website at http://investors.elutia.com/.
About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
Investors:
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com
FAQ
When will Elutia (ELUT) release Q4 and full year 2024 earnings?
What time is Elutia's (ELUT) Q4 2024 earnings call?
How can investors access Elutia's (ELUT) Q4 2024 earnings call?
Where can I find the webcast of Elutia's (ELUT) Q4 2024 earnings call?
